Orchestra BioMed (NASDAQ:OBIO) Issues Earnings Results, Beats Expectations By $0.10 EPS

Résumé détaillé

Orchestra BioMed (NASDAQ:OBIO - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.30) EPS for the quarter, beating analysts' consensus estimates of ($0.40) by $0.10. The company had revenue of $0.09 million during the quarter, compared to the consensus estimate of $0.13 million. Orchestra BioMed had a negative net margin of 184.60% and a negative return on equity of 149.61%.